J&J explores $20 billion sale of orthopedics unit: source

Johnson & Johnson is preparing a potential sale of its orthopedics unit, in a deal that could top $20 billion, with the company eyeing private equity firms as the most likely buyers, a source familiar with the matter has told Reuters.The company did not immediately respond to a Reuters request for comment.J&J last year said it had planned to separate its orthopedics unit, known as DePuy Synthes, into a standalone company within the next 18 to 24 months, marking its second major spinoff in two years as it sh ...